How Does DT1 Sphere Perform in Current and Successful Acuvue MAX Wearers?

August 7, 2025 updated by: Southern College of Optometry
The goal of this prospective study is to to understand if satisfied MAX Contact lens (CL)wearers can be successfully refit into Dailies total 1 (DT1) CL in healthy MAX CL wearers between the ages of 18-40. The main question is to determine the number of participants who can successfully be re-fit into DT1 CL, by utilizing a cldeq-8 questionnaire as well as an investigator developed questionnaire to gauge comfort and satisfaction.

Study Overview

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tennessee
      • Memphis, Tennessee, United States, 38104
        • The Southern College of Optometry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

  • Inclusion Criteria:
  • Adults, 18- to 40-year-old, Oasys MAX 1-day CL wearers with best-corrected 20/20 visual acuity or better.
  • Participants will be required to have worn Oasys MAX 1-day CLs for at least 3 months in the past year and currently wearing these CLs.
  • All participants will be required to have a CLDEQ-8 score <12 while wearing their habitual CLs (Oasys MAX 1-days) and to indicate that they are satisfied with Oasys MAX 1-day CLs (Yes/No).
  • Participants will be required to be able to wear DT1 Sphere CLs (astigmatism < 0.75D OD/OS).
  • Participants will be required to wear the study CLs for ≥12 hours with no overnight wear
  • Participants will be required to use digital devices at least 8 hours/day.
  • Participants will be required to provide a glasses prescription that is less than 3 years old.
  • Exclusion Criteria:
  • Have presbyopia and/or need a reading add as determined during their initial manifest refraction.
  • Have worn DT1 in the past for more than 1 week.
  • Are past rigid CL wearers.
  • Have a history of being diagnosed with dry eye or ocular allergies.
  • Have known systemic health conditions that are thought to alter tear film physiology.
  • Have corrected acuity 1 line or more worse vision recorded at Visit 2 (compared to the Visit 1 findings) with their optimized Oasys MAX 1-day lenses.
  • Have a history of viral eye disease.
  • Have a history of ocular surgery.
  • Have a history of severe ocular trauma.
  • Have a history of corneal dystrophies or degenerations.
  • Have active ocular infection or inflammation.
  • Are currently using isotretinoin-derivatives or ocular medications.
  • Are pregnant or breast feeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dailies total 1 contact lenses
Acuvue max wearers will be refit into dailies total 1
successful refit into dt1 will be determined

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Likelihood of continuing to wear DT1
Time Frame: 3 weeks
A Likert questionnaire will be used to determine patient-reported outcomes -50 being uncomfortable and 50 being extremely comfortbale
3 weeks
Overall satisfaction while wearing DT1
Time Frame: 3 weeks
A Likert questionnaire will be used to determine patient-reported outcomes. With answers that are positive such as strongly agree to product satisfaction are better.
3 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2024

Primary Completion (Actual)

November 1, 2024

Study Completion (Actual)

November 30, 2024

Study Registration Dates

First Submitted

February 21, 2025

First Submitted That Met QC Criteria

February 21, 2025

First Posted (Actual)

February 26, 2025

Study Record Updates

Last Update Posted (Actual)

August 12, 2025

Last Update Submitted That Met QC Criteria

August 7, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2024-07-01CL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Contact Lens Comfort and Successful Refitting

Clinical Trials on Dailies total 1 contact lenses

Subscribe